BackBrooklyn ImmunoTherapeutics Overview

Brooklyn ImmunoTherapeutics Total Revenue

Revenue analysis for BTX.

Quarterly Revenue

$487000.00
↑ 854.9% YoY

As of Sep 2024

Annual Revenue (TTM)

$598000.00
↑ 1072.55% YoY

Trailing 12 months ending Sep 2024

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin